PRKAA1 and cancer: In contrast, no significant apoptosis activation was detected in primary (“pEpi”) and established (BEAS-2B) lung epithelial cells with the same ASP4132 treatment (Fig. 2I), further supporting cancer cell specific response by the AMPK activator.